Oxidative Stress Assay Market

Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End Users (Pharma & Biotech) - Global Forecasts to 2025

Report Code: BT 3416 Apr, 2021, by marketsandmarkets.com

[189 Pages Report] The market for oxidative stress assay is expected to grow from USD 836 million in 2020 to USD 1,326 million by 2025, at a CAGR of 9.7% during the forecast period. Growth in the oxidative stress assay market is attributed to factors such as the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of this market include technological advancements like HCS for drug discovery, increasing R&D expenditure in biotechnology and pharmaceutical industries, and government support for pharmaceutical and biotechnology industries.

Oxidative Stress Assay Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the Global Oxidative Stress Assay Market

COVID-19 is expected to have a low-to-moderate impact on the oxidative stress assays market due to its impact on research and manufacturing activities worldwide. The economic impact of COVID-19 on companies and financial markets was an unfavorable one. Stock market volatility and decreasing global growth during the pandemic have affected several industries. The oxidative stress assays market has experienced a slight downturn due to strict government regulations, disruptions in the supply chain, and low research and development activities. However, with academic research and other commercial activities picking up pace, the market is estimated to grow in the coming years.

Oxidative Stress Assay Market Dynamics

Market Dynamics

Driver: Rapid growth in biopharmaceutical and biotechnology industry

The global biopharmaceuticals market was valued at ~USD 275 billion in 2018 and is estimated to grow at 12–13% annually (Source: 16th Annual Report and Survey of Biopharmaceutical Manufacturing, April 2019). Similarly, the global pharmaceutical market is expected to grow over USD 1.5 trillion by 2023 from the USD 1.2 trillion of 2018, at an annual growth rate of 3–6% (Source: The Global Use of Medicine in 2019 and Outlook to 2023).

A similar growth trend is observed in the biotechnology industry. For example, companies in biotech centers such in the US registered over USD 112 billion in revenue and had a total market capitalization of ~USD 700 billion in 2018. Currently, more than 130,000 people are employed by public biotechnology companies in the US (Source: biotecnika.org, January 2020). According to OECD estimates, in 2018, the total number of biotechnology companies that were active in the US was 2,470. In France, another major biotech market, this number was 2,083.

Oxidative stress assays are widely used in cell cultures used for biopharmaceutical production. Owing to this, biopharmaceutical and biotechnology companies are the largest end users of oxidative stress assays. Rapid growth in these industries is thus expected to drive the growth of the oxidative stress assays market..

Restraint : High cost of instruments

High-content screening and label-free detection technologies for oxidative stress assays offer many advantages over conventional technologies. These instruments are equipped with advanced features and functionalities and thus are priced at a premium. For instance, a confocal microscope used in HCS can cost up to USD 250,000. Thus, owing to their high cost, companies with smaller R&D budgets cannot afford these expensive instruments. On the other hand, pharmaceutical companies require many such systems, and hence their capital cost increases significantly. Furthermore, academic research laboratories find it difficult to invest in such systems as they have controlled budgets. Hence, the high costs associated with technological advancements may hinder the growth of the overall market.

Opportunity: Emerging Economies present significant growth opportunities

Emerging markets such as Brazil, Russia, India, China, and South Africa (BRICS) are expected to present significant opportunities for the growth of the oxidative stress assays market. This can mainly be attributed to increased R&D funding for various research organizations in these countries.

In China, R&D investments by public and private science and technology organizations increased by 12.5% between 2018 and 2019 to USD 322 billion (Source: National Bureau of Statistics); spending on basic research accounted for 6% of the total investments, while applied research and development accounted for 11.3% and 82.7%, respectively.

Emerging economies in Asia are experiencing rapid growth in healthcare expenditure. According to estimates from the World Bank, global healthcare spending increased from 1.995% of the GDP in 2013 to 2.274% of the GDP by 2018. Asian markets, especially China and India, have a large number of CROs that offer drug discovery services to serve the pharmaceutical and biotechnology industries. The global CRO market reached USD 39 billion in 2018 and is expected to exceed USD 44 billion by 2021, as patent expiration, proliferation of generic medications, and technological innovations like mHealth and big data influence product development. This will result in greater outsourcing of work to CROs (Source: Top 10 Contract Research Organisations to Watch in 2019). Growth in the CRO industry is expected to offer potential growth opportunities for oxidative stress assay manufacturers.

“By product, the consumables segment is expected to grow at the highest CAGR during the forecast period.”

On the basis of product, the oxidative stress assay market is segmented into consumables, instruments, and services. Consumables is the largest and fastest-growing segment,  in 2020. This segment is also projected to register the highest CAGR from 2020 to 2025. The recurring requirement of consumables as compared to instruments is the key factor driving the growth of this segment.

“By diseases type, cardiovascular diseases accounted for the largest share of the disease type market in 2020”

Based on disease type, the oxidative stress assays market is segmented into cardiovascular diseases, diabetes, cancer, respiratory diseases, and other diseases. The cardiovascular diseases segment accounted for the largest share of this market in 2020, primarily due to the high and growing prevalence of cardiovascular diseases across the globe.

North America accounted for the largest share of the oxidative stress assay market in 2020, while the Asia Pacific market is expected to register the highest growth during the forecast period

The oxidative stress assay market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and Rest of the World. North America accounted for the largest share of  of the global oxidative stress assay market in 2020. However, the Asia Pacific market is expected to register the highest CAGR during the forecast period.

Oxidative Stress Assay Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The major players in the oxidative stress assay market are Merck KGaA  (Germany),  Thermo Fisher Scientific, Inc  (US), and QIAGEN N.V.  (Netherlands). These companies together accounted for a share of approximately 60% of the oxidative stress assay market in 2019. Other players in the market include Abcam, plc (UK), Enzo Biochem, Inc. (US), AMS Biotechnology (Europe), Ltd. (UK), BioVision, Inc. (US), Cell Biolabs, Inc. (US), Oxford Biomedical Research (US), Promega Corporation (US), Cayman Chemical (US), Eagle Biosciences, Inc. (US), Arbor Assays (US), Hycult Biotech (Netherlands), Callegari SRL (Italy), Kamiya Biomedical Company (US), MEGA TIP San.Tic.Ltd.Sti. (Turkey), ImmunoChemistry Technologies, LLC (US), Genox Corporation (US), and Toxys B.V. (Netherlands).

Scope of Market

Report Metric

Details

Market Size Available for Years

2018–2025

Base Year Considered

2019

Forecast Period

2020–2025

Forecast Units

Value (USD)

Segments Covered

Test type, Product, Technology, Disease type, End User and Region

Geographies Covered

North America (US and Canada), Europe (Germany, France, UK, Italy, Spain and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), and Rest of the World

Companies Covered

Abcam, plc (UK), Enzo Biochem, Inc. (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), AMS Biotechnology (Europe), Ltd. (UK), BioVision, Inc. (US), Cell Biolabs, Inc. (US), Oxford Biomedical Research (US), Promega Corporation (US), Cayman Chemical (US), Eagle Biosciences, Inc. (US), Arbor Assays (US), Hycult Biotech (Netherlands), Callegari SRL (Italy), Kamiya Biomedical Company (US), MEGA TIP San.Tic.Ltd.Sti. (Turkey), ImmunoChemistry Technologies, LLC (US), Genox Corporation (US), and Toxys B.V. (Netherlands).

This research report categorizes the oxidative stress assay market into the following segments:

Oxidative stress assay Market, by Product

  • Consumables
  • Kits 
  • Reagents
  • Instruments
  • Services

Oxidative stress assay Market, by Test Type

  • Antioxidant Capacity Assays
  • Ascorbic Acid Assays
  • Glutathione Assays
  • Cell-based Exogenous Antioxidant Assays
  • Indirect Assays
  • Lipid-based Assays
  • Nucleic Acid-based Assays
  • Protein-based Assays
  • Enzyme-based Assays
  • Reactive Oxygen Species-based Assays

Oxidative stress assay Market, by Technology

  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Flow Cytometry
  • High-content Screening (HCS)
  • Label-free Detection
  • Microscopy
  • Chromatography

Oxidative stress assay Market, by Disease Type

  • Cardiovascular Disease
  • Diabetes
  • Cancer
  • Respiratory Diseases
  • Other Diseases

Oxidative stress assay Market, by End User

  • Clinical Laboratories
  • Contract Research Organizations
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Cosmetic Companies

Oxidative stress assay Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World

Recent Developments:

  • In 2020, Abcam plc (UK) Acquired Expedeon’s (Germany) Proteomics and Immunology business for enhancing its conjugation capability
  • In 2018, Abcam plc (UK) had an agreement with QIAGEN (Suzhou) and signed a strategic MoU collaboration agreement to co-develop companion diagnostic (CDx) and in vitro diagnostic (IVD) reagents and kits for the Chinese market.
  • In 2018, BioVision, Inc. (US) launched the nitrite Assay Kit (Griess Reagent)
  • In 2020, Cayman Chemical (US)  started building a USD 20-million research and development facility at its headquarters in the US.  

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 30)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKETS COVERED
        FIGURE 1 OXIDATIVE STRESS ASSAYS MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
        FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
           2.1.3 KEY INDUSTRY INSIGHTS
                 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
                 FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.2.2 GROWTH FORECAST
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION
        FIGURE 5 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 42)
  FIGURE 6 OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
  FIGURE 7 OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2020 VS. 2025 (USD MILLION)
  FIGURE 8 OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
  FIGURE 9 OXIDATIVE STRESS ASSAYS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 45)
    4.1 OXIDATIVE STRESS ASSAYS MARKET OVERVIEW
        FIGURE 10 GROWING R&D EXPENDITURE IN PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRIES TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET (2020)
        FIGURE 11 OXIDATIVE STRESS ASSAY KITS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET
    4.3 OXIDATIVE STRESS ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
        FIGURE 12 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 13 OXIDATIVE STRESS ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
           5.2.1 DRIVERS
                    5.2.1.1 Rapid growth in the biopharmaceutical and biotechnology industries
                    5.2.1.2 Growing R&D expenditure in the pharmaceutical & biopharmaceutical industries
                            FIGURE 14 R&D SPENDING OF PHRMA MEMBER COMPANIES, 2005–2019 (USD BILLION)
                    5.2.1.3 Technological advancements such as high-content screening for drug discovery
                    5.2.1.4 Government funding for life science research
                    5.2.1.5 Emergence of label-free detection technologies
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of instruments
                    5.2.2.2 Shortage of trained personnel for new and emerging technologies
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging economies present significant growth opportunities
                    5.2.3.2 Applications of oxidative stress measurement in the cosmetic industry
    5.3 PORTER’S FIVE FORCES ANALYSIS
        TABLE 1 OXIDATIVE STRESS ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 DEGREE OF COMPETITION
    5.4 SUPPLY CHAIN ANALYSIS
        FIGURE 15 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.5 VALUE CHAIN ANALYSIS
        FIGURE 16 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
    5.6 ECOSYSTEM ANALYSIS OF THE OXIDATIVE STRESS ASSAYS MARKET
        FIGURE 17 ECOSYSTEM ANALYSIS
    5.7 COVID-19 IMPACT ANALYSIS

6 OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE (Page No. - 58)
    6.1 INTRODUCTION
        TABLE 2 OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
    6.2 CONSUMABLES
        TABLE 3 OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 4 OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.1 KITS
                    6.2.1.1 Kits accounted for the largest share of the oxidative stress assays market
                            TABLE 5 OXIDATIVE STRESS ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.2 REAGENTS
                    6.2.2.1 Antibodies are the most widely used reagents in oxidative stress assays
                            TABLE 6 OXIDATIVE STRESS ASSAY REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
    6.3 INSTRUMENTS
           6.3.1 INSTRUMENTS SEGMENT TO WITNESS LOWER GROWTH THAN THE CONSUMABLES SEGMENT
                 TABLE 7 OXIDATIVE STRESS ASSAY INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
    6.4 SERVICES
           6.4.1 SERVICES SEGMENT TO ACCOUNT FOR A LOW SHARE OF THE MARKET DURING THE FORECAST PERIOD
                 TABLE 8 OXIDATIVE STRESS ASSAY SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)

7 OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY (Page No. - 63)
    7.1 INTRODUCTION
        TABLE 9 OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
    7.2 ELISA
           7.2.1 ELISA SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
                 TABLE 10 OXIDATIVE STRESS ASSAYS MARKET FOR ELISA, BY REGION, 2018–2025 (USD MILLION)
    7.3 FLOW CYTOMETRY
           7.3.1 FLOW CYTOMETRY IS USEFUL FOR THE MEASUREMENT OF CELLULAR OXIDATIVE STRESS
                 TABLE 11 OXIDATIVE STRESS ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2018–2025 (USD MILLION)
    7.4 CHROMATOGRAPHY
           7.4.1 GAS CHROMATOGRAPHY IS THE PREFERRED METHOD FOR THE ANALYSIS OF HNE
                 TABLE 12 OXIDATIVE STRESS ASSAYS MARKET FOR CHROMATOGRAPHY, BY REGION, 2018–2025 (USD MILLION)
    7.5 MICROSCOPY
           7.5.1 DIGITAL MICROSCOPES WITH ADVANCED FEATURES ARE USED TO EVALUATE OXIDATIVE STRESS
                 TABLE 13 OXIDATIVE STRESS ASSAYS MARKET FOR MICROSCOPY, BY REGION, 2018–2025 (USD MILLION)
    7.6 HIGH-CONTENT SCREENING
           7.6.1 HCS IS AN EMERGING TECHNOLOGY IN THE OXIDATIVE STRESS ASSAYS MARKET
                 TABLE 14 OXIDATIVE STRESS ASSAYS MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2018–2025 (USD MILLION)
    7.7 LABEL-FREE DETECTION
           7.7.1 LABEL-FREE DETECTION SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
                 TABLE 15 OXIDATIVE STRESS ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION, 2018–2025 (USD MILLION)

8 OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE (Page No. - 70)
    8.1 INTRODUCTION
        TABLE 16 OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
    8.2 INDIRECT ASSAYS
        TABLE 17 OXIDATIVE STRESS ASSAYS MARKET FOR INDIRECT ASSAYS, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 18 OXIDATIVE STRESS ASSAYS MARKET FOR INDIRECT ASSAYS, BY REGION, 2018–2025 (USD MILLION)
           8.2.1 PROTEIN-BASED ASSAYS
                    8.2.1.1 Protein-based assays accounted for the largest share of the indirect assays market
                            TABLE 19 OXIDATIVE STRESS ASSAYS MARKET FOR PROTEIN-BASED ASSAYS, BY REGION, 2018–2025 (USD MILLION)
           8.2.2 LIPID-BASED ASSAYS
                    8.2.2.1 The most commonly used lipid peroxidation assays are MDA assays
                            TABLE 20 OXIDATIVE STRESS ASSAYS MARKET FOR LIPID-BASED ASSAYS, BY REGION, 2018–2025 (USD MILLION)
           8.2.3 NUCLEIC ACID-BASED ASSAYS
                    8.2.3.1 Nucleic acid-based assays accounted for the lowest share of the indirect assays market
                            TABLE 21 OXIDATIVE STRESS ASSAYS MARKET FOR NUCLEIC ACID-BASED ASSAYS, BY REGION, 2018–2025 (USD MILLION)
    8.3 ANTIOXIDANT CAPACITY ASSAYS
        TABLE 22 OXIDATIVE STRESS ASSAYS MARKET FOR ANTIOXIDANT CAPACITY ASSAYS, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 23 OXIDATIVE STRESS ASSAYS MARKET FOR ANTIOXIDANT CAPACITY ASSAYS, BY REGION, 2018–2025 (USD MILLION)
           8.3.1 GLUTATHIONE ASSAYS
                    8.3.1.1 Glutathione assays accounted for the largest share of the antioxidant capacity assays market
                            TABLE 24 OXIDATIVE STRESS ASSAYS MARKET FOR GLUTATHIONE ASSAYS, BY REGION, 2018–2025 (USD MILLION)
           8.3.2 ASCORBIC ACID ASSAYS
                    8.3.2.1 Ascorbic acid assay kits are based on FRASC chemistry
                            TABLE 25 OXIDATIVE STRESS ASSAYS MARKET FOR ASCORBIC ACID ASSAYS, BY REGION, 2018–2025 (USD MILLION)
           8.3.3 CELL-BASED EXOGENOUS ANTIOXIDANT ASSAYS
                    8.3.3.1 These assays are used for measuring the activity of an exogenous antioxidant compound within adherent cells
                            TABLE 26 OXIDATIVE STRESS ASSAYS MARKET FOR CELL-BASED EXOGENOUS ANTIOXIDANT ASSAYS, BY REGION, 2018–2025 (USD MILLION)
    8.4 ENZYME-BASED ASSAYS
           8.4.1 CATALASE ACTIVITY ASSAYS AND SOD ASSAYS ARE THE TWO TYPES OF ENZYME-BASED ASSAYS AVAILABLE IN THE MARKET
                 TABLE 27 OXIDATIVE STRESS ASSAYS MARKET FOR ENZYME-BASED ASSAYS, BY REGION, 2018–2025 (USD MILLION)
    8.5 REACTIVE OXYGEN SPECIES-BASED ASSAYS
           8.5.1 ROS ASSAY KITS MEASURE THE ACTIVITY OF HYDROXYL, PEROXYL, AND OTHER REACTIVE OXYGEN SPECIES
                 TABLE 28 OXIDATIVE STRESS ASSAYS MARKET FOR REACTIVE OXYGEN SPECIES-BASED ASSAYS, BY REGION, 2018–2025 (USD MILLION)

9 OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE (Page No. - 80)
    9.1 INTRODUCTION
        TABLE 29 OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
    9.2 CARDIOVASCULAR DISEASES
           9.2.1 HIGH PREVALENCE OF CARDIOVASCULAR DISEASES WILL DRIVE MARKET GROWTH
                 TABLE 30 OXIDATIVE STRESS ASSAYS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018–2025 (USD MILLION)
    9.3 CANCER
           9.3.1 RISING INCIDENCE OF CANCER TO DRIVE MARKET GROWTH
                 FIGURE 18 WORLDWIDE ESTIMATED NUMBER OF NEW CANCER CASES IN FEMALES (ALL AGE GROUPS), 2020
                 FIGURE 19 WORLDWIDE ESTIMATED NUMBER OF NEW CANCER CASES IN MALES (ALL AGE GROUPS), 2020
                 TABLE 31 OXIDATIVE STRESS ASSAYS MARKET FOR CANCER, BY REGION, 2018–2025 (USD MILLION)
    9.4 DIABETES
           9.4.1 HIGH AND GROWING PREVALENCE OF DIABETES TO BOOST MARKET GROWTH
                 TABLE 32 OXIDATIVE STRESS ASSAYS MARKET FOR DIABETES, BY REGION, 2018–2025 (USD MILLION)
    9.5 RESPIRATORY DISEASES
           9.5.1 RISING PREVALENCE OF COPD TO BOOST MARKET GROWTH
                 TABLE 33 OXIDATIVE STRESS ASSAYS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2025 (USD MILLION)
    9.6 OTHER DISEASES
        TABLE 34 OXIDATIVE STRESS ASSAYS MARKET FOR OTHER DISEASES, BY REGION, 2018–2025 (USD MILLION)

10 OXIDATIVE STRESS ASSAYS MARKET, BY END USER (Page No. - 87)
     10.1 INTRODUCTION
          TABLE 35 OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
             10.2.1 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF OXIDATIVE STRESS ASSAYS
                    TABLE 36 OXIDATIVE STRESS ASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
     10.3 ACADEMIC RESEARCH INSTITUTES
             10.3.1 STRENGTHENING OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH
                    FIGURE 20 PUBLIC-SECTOR RESEARCH FUNDING IS DRIVING THE GROWTH OF THE ACADEMIC RESEARCH INSTITUTES SEGMENT (2018–2020)
                    TABLE 37 OXIDATIVE STRESS ASSAYS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
     10.4 CLINICAL LABORATORIES
             10.4.1 OXIDATIVE STRESS ASSAYS ARE USED IN PRECLINICAL BIOLOGICAL TESTING
                    TABLE 38 OXIDATIVE STRESS ASSAYS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
     10.5 CONTRACT RESEARCH ORGANIZATIONS
             10.5.1 OUTSOURCING OF PHARMACEUTICAL R&D ACTIVITIES TO DRIVE MARKET GROWTH
                    TABLE 39 OXIDATIVE STRESS ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
     10.6 COSMETIC INDUSTRY
             10.6.1 ADOPTION OF OXIDATIVE STRESS ASSAYS IS EXPECTED TO INCREASE IN THE COSMETIC INDUSTRY
                    TABLE 40 OXIDATIVE STRESS ASSAYS MARKET FOR COSMETIC INDUSTRY, BY REGION, 2018–2025 (USD MILLION)

11 OXIDATIVE STRESS ASSAYS MARKET, BY REGION (Page No. - 93)
     11.1 INTRODUCTION
          TABLE 41 OXIDATIVE STRESS ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
     11.2 NORTH AMERICA
          FIGURE 21 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET SNAPSHOT
          TABLE 42 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 43 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
          TABLE 44 NORTH AMERICA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 45 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
          TABLE 46 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
          TABLE 47 NORTH AMERICA: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 48 NORTH AMERICA: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 49 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
          TABLE 50 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.2.1 US
                        11.2.1.1 The US is the largest market for oxidative stress assays
                                 TABLE 51 US: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 52 US: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 53 US: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 54 US: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 55 US: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 56 US: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 57 US: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 58 US: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Increasing biopharmaceutical industry to drive market growth in Canada
                                 TABLE 59 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 60 CANADA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 61 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 62 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 63 CANADA: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 64 CANADA: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 65 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 66 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
     11.3 EUROPE
          TABLE 67 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 68 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
          TABLE 69 EUROPE: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 70 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
          TABLE 71 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
          TABLE 72 EUROPE: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 73 EUROPE: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 74 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
          TABLE 75 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Germany is the largest market for oxidative stress assay products in Europe
                                 TABLE 76 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 77 GERMANY: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 78 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 79 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 80 GERMANY: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 81 GERMANY: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 82 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 83 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 High burden of CVD in the UK to drive the adoption of oxidative stress assay products
                                 TABLE 84 UK: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 85 UK: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 86 UK: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 87 UK: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 88 UK: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 89 UK: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 90 UK: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 91 UK: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Rising prevalence of COPD in France to drive market growth
                                 TABLE 92 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 93 FRANCE: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 94 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 95 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 96 FRANCE: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 97 FRANCE: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 98 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 99 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.4 ITALY
                        11.3.4.1 Sluggish growth in the Italian healthcare sector to hamper market growth
                                 TABLE 100 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 101 ITALY: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 102 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 103 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 104 ITALY: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 105 ITALY: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 106 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 107 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.5 SPAIN
                        11.3.5.1 Rising prevalence of chronic diseases to support market growth
                                 TABLE 108 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 109 SPAIN: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 110 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 111 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 112 SPAIN: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 113 SPAIN: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 114 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 115 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.6 REST OF EUROPE
                    TABLE 116 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                    TABLE 117 ROE: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 118 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                    TABLE 119 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                    TABLE 120 ROE: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 121 ROE: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 122 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                    TABLE 123 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
     11.4 ASIA PACIFIC
          TABLE 124 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 125 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
          TABLE 126 ASIA PACIFIC: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 127 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
          TABLE 128 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
          TABLE 129 ASIA PACIFIC: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 130 ASIA PACIFIC: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 131 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
          TABLE 132 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.4.1 JAPAN
                        11.4.1.1 Japan is the largest market for oxidative stress assays in the APAC
                                 TABLE 133 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 134 JAPAN: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 135 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 136 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 137 JAPAN: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 138 JAPAN: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 139 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 140 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.4.2 CHINA
                        11.4.2.1 China is the fastest-growing market for oxidative stress assays
                                 TABLE 141 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 142 CHINA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 143 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 144 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 145 CHINA: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 146 CHINA: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 147 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 148 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Rising prevalence of chronic diseases to propel market growth
                                 TABLE 149 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                                 TABLE 150 INDIA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 151 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 152 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                                 TABLE 153 INDIA: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 154 INDIA: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 155 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                                 TABLE 156 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.4.4 REST OF ASIA PACIFIC
                    TABLE 157 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
                    TABLE 158 ROAPAC: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 159 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                    TABLE 160 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
                    TABLE 161 ROAPAC: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 162 ROAPAC: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 163 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
                    TABLE 164 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
     11.5 REST OF THE WORLD
          TABLE 165 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
          TABLE 166 ROW: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 167 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
          TABLE 168 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
          TABLE 169 ROW: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 170 ROW: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 171 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION)
          TABLE 172 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 144)
     12.1 OVERVIEW
          FIGURE 22 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN JANUARY 2017 AND DECEMBER 2020
          FIGURE 23 MARKET EVOLUTION FRAMEWORK
     12.2 MARKET SHARE ANALYSIS
             12.2.1 INTRODUCTION
                    FIGURE 24 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
     12.3 COMPANY EVALUATION MATRIX
             12.3.1 STARS
             12.3.2 EMERGING LEADERS
             12.3.3 PERVASIVE PLAYERS
             12.3.4 PARTICIPANTS
                    FIGURE 25 OXIDATIVE STRESS ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
     12.4 COMPETITIVE SITUATIONS AND TRENDS
             12.4.1 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2020)
                    TABLE 173 OXIDATIVE STRESS ASSAYS MARKET: KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2020)
             12.4.2 KEY PRODUCT LAUNCHES (2017–2020)
                    TABLE 174 OXIDATIVE STRESS ASSAYS MARKET: KEY PRODUCT LAUNCHES (2017–2020)
             12.4.3 KEY ACQUISITIONS (2017–2020)
                    TABLE 175 OXIDATIVE STRESS ASSAYS MARKET: KEY ACQUISITIONS (2017–2020)
             12.4.4 KEY EXPANSIONS (2017–2020)
                    TABLE 176 OXIDATIVE STRESS ASSAYS MARKET: KEY EXPANSIONS (2017–2020)

13 COMPANY PROFILES (Page No. - 151)
     13.1 MAJOR PLAYERS
(Business overview, Products offered, Recent developments, MNM view)*
             13.1.1 ABCAM PLC
                    TABLE 177 ABCAM PLC: BUSINESS OVERVIEW
                    FIGURE 26 ABCAM PLC: COMPANY SNAPSHOT (2019)
                    TABLE 178 ABCAM PLC: PRODUCTS OFFERED
             13.1.2 ENZO BIOCHEM, INC.
                    TABLE 179 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW
                    FIGURE 27 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2019)
                    TABLE 180 ENZO BIOCHEM, INC.: PRODUCTS OFFERED
             13.1.3 MERCK KGAA
                    TABLE 181 MERCK KGAA: BUSINESS OVERVIEW
                    FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2019)
                    TABLE 182 MERCK KGAA: PRODUCTS OFFERED
             13.1.4 QIAGEN N.V.
                    TABLE 183 QIAGEN N.V.: BUSINESS OVERVIEW
                    FIGURE 29 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
                    TABLE 184 QIAGEN N.V.: PRODUCTS OFFERED
             13.1.5 THERMO FISHER SCIENTIFIC, INC.
                    TABLE 185 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                    FIGURE 30 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
                    TABLE 186 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED
             13.1.6 AMS BIOTECHNOLOGY (EUROPE) LTD.
                    TABLE 187 AMS BIOTECHNOLOGY (EUROPE), LTD.: BUSINESS OVERVIEW
                    TABLE 188 AMS BIOTECHNOLOGY (EUROPE) LTD.: PRODUCTS OFFERED
             13.1.7 BIOVISION, INC.
                    TABLE 189 BIOVISION, INC.: BUSINESS OVERVIEW
                    TABLE 190 BIOVISION, INC.: PRODUCTS OFFERED
             13.1.8 CELL BIOLABS, INC.
                    TABLE 191 CELL BIOLABS, INC.: BUSINESS OVERVIEW
                    TABLE 192 CELL BIOLABS, INC.: PRODUCTS OFFERED
             13.1.9 OXFORD BIOMEDICAL RESEARCH
                    TABLE 193 OXFORD BIOMEDICAL RESEARCH: BUSINESS OVERVIEW
                    TABLE 194 OXFORD BIOMEDICAL RESEARCH: PRODUCTS OFFERED
             13.1.10 CAYMAN CHEMICAL
                    TABLE 195 CAYMAN CHEMICAL: BUSINESS OVERVIEW
                    TABLE 196 CAYMAN CHEMICAL: PRODUCTS OFFERED
     13.2 OTHER PLAYERS
             13.2.1 EAGLE BIOSCIENCES, INC.
                    TABLE 197 EAGLE BIOSCIENCES, INC.: BUSINESS OVERVIEW
                    TABLE 198 EAGLE BIOSCIENCES, INC.: PRODUCTS OFFERED
             13.2.2 ARBOR ASSAYS
                    TABLE 199 ARBOR ASSAYS.: BUSINESS OVERVIEW
                    TABLE 200 ARBOR ASSAYS: PRODUCTS OFFERED
             13.2.3 HYCULT BIOTECH
                    TABLE 201 HYCULT BIOTECH: BUSINESS OVERVIEW
                    TABLE 202 HYCULT BIOTECH: PRODUCTS OFFERED
             13.2.4 KAMIYA BIOMEDICAL COMPANY
                    TABLE 203 KAMIYA BIOMEDICAL COMPANY: BUSINESS OVERVIEW
                    TABLE 204 KAMIYA BIOMEDICAL COMPANY: PRODUCTS OFFERED
             13.2.5 MEGA TIP SAN.TIC.LTD.STI.
                    TABLE 205 MEGA TIP SAN.TIC.LTD.STI.: BUSINESS OVERVIEW
                    TABLE 206 MEGA TIP SAN.TIC.LTD.STI.: PRODUCTS OFFERED
             13.2.6 PROMEGA CORPORATION
             13.2.7 CALLEGARI SRL
             13.2.8 IMMUNOCHEMISTRY TECHNOLOGIES, LLC
             13.2.9 GENOX CORPORATION
             13.2.10 TOXYS B.V.

*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 182)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS

The study involved four major activities in estimating the current market size for oxidative stress assay. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to, so as to identify and collect information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information as well as assess future prospects.

Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, opportunities, challenges, industry trends, and strategies adopted by key players.

Oxidative Stress Assay Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the oxidative stress assay market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and to arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides, in the fluoroscopy industry.

Report Objectives

  • To define, describe, and measure the oxidative stress assay market by test type, product, technology, disease type, end user and region
  • To provide detailed information about the major factors influencing market growth (such as drivers, restraints, and growth opportunities)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the oxidative stress assay market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market in North America, Europe, Asia Pacific (APAC), and Rest of the World
  • To strategically analyze the market structure and profile key players and their core competencies3 in the oxidative stress assay market
  • To track and analyze competitive developments such as product launches, expansions, acquisitions, and partnerships & collaborations in the oxidative stress assay market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present oxidative stress assay market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company (Top 3 companies)

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Oxidative Stress Assay Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Oxidative Stress Assay Market

Request For Special Pricing
Report Code
BT 3416
Published ON
Apr, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Oxidative Stress Assay Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home